Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Taurolidine Citrate and Unfractionated Heparin Combination Versus Unfractionated Heparin Alone in Prevention of Inflammation in Hemodialysis Catheters.

NCT03539718 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03539718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03539718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Taurolidine Citrate and Unfractionated Heparin Combination Versus Unfractionated Heparin Alone in Prevention of Inflammation in Hemodialysis Catheters.
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Unknown status
Start date
May 15, 2018
Completion date
February 28, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis catheter infection, thrombosis; dialysis catheter